Skip to content

RS Research vs Barinthus Biotherapeutics

RS Research logo

RS Research

Clinically-validated biotech company for targeted therapies, disrupting the efficacy-toxicity trade-off

30 employees · est. 2015 · Istanbul, Turkey

VS
Barinthus Biotherapeutics logo

Barinthus Biotherapeutics

Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates

34 employees · est. 2016 · Oxford, United Kingdom

RS Research is the older company (2015 vs 2016).

Side-by-Side Comparison

RS Research Barinthus Biotherapeutics
Founded
2015 older 2016
Headquarters
Istanbul, Turkey Oxford, United Kingdom
Employees
30 34
Industry
Biotechnology, Pharmaceutical Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage
Series A Acquired
Total Funding
$14.00M $146.66M
Funding Rounds
4 7
Services
Development of targeted oncology therapies, Sagitta® drug delivery platform, Clinical trials for cancer treatment Development of antigen-specific immunotherapies, Phase 1b/2 clinical trials, Pipeline management for autoimmune diseases and chronic viral infections, Biopharmaceutical research and development
Target Customers
Oncologists, Pharmaceutical companies, Research institutions, Healthcare providers Patients with autoimmune and inflammatory conditions, Patients with chronic viral infections, Healthcare providers, Oncologists
Taxonomy
Clinical-stage BiotechnologySmart NanomedicinesTargeted ChemotherapyDrug Delivery PlatformSagitta®Cancer Therapy +9 T-cell ImmunotherapeuticsChronic Infectious DiseasesAutoimmunityCancer TreatmentChAdOx TechnologyMVA Boost Vector +9
Website
rsresearch.net barinthusbio.com
RS Research logo

About RS Research

RS Research is a clinical-stage biotechnology start-up headquartered in Turkey that is at the forefront of developing smart nanomedicines for targeted chemotherapy. Established in 2015, the company leverages its innovative drug delivery platform, Sagitta®, aiming to provide a “Cure With a Smile” thr...

Barinthus Biotherapeutics logo

About Barinthus Biotherapeutics

Barinthus Biotherapeutics, founded in 2016, is a United Kingdom-based clinical-stage biopharmaceutical company that is innovating in the realms of Biotechnology, Health and Wellness, and Pharmaceutical industries. The company specializes in developing novel T-cell immunotherapeutic candidates aimed...

Also comparing in this category

Comparing more than these two?

Get RS Research, Barinthus Biotherapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does RS Research compare?

A PDF of RS Research and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

RS Research was founded in 2015, based in Istanbul, Turkey, with 30 employees. RS Research is a clinical-stage biotechnology start-up headquartered in Turkey that is at the forefront of developing smart nanomedicines for targeted chemotherapy. Established in 2015, the company le. Barinthus Biotherapeutics was founded in 2016, based in Oxford, United Kingdom, with 34 employees. Barinthus Biotherapeutics, founded in 2016, is a United Kingdom-based clinical-stage biopharmaceutical company that is innovating in the realms of Biotechnology, Health and Wellness, and Pharmaceutica.
RS Research has raised $14.00M and Barinthus Biotherapeutics $146.66M. Latest stage: RS Research Series A, Barinthus Biotherapeutics Acquired.
Both work in Biotechnology and Pharmaceutical.

Compare RS Research with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at RS Research on 4 Mar 2026, and Barinthus Biotherapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout